• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form F-3/A filed by Meiwu Technology Company Limited

    2/23/26 11:39:14 AM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $WNW alert in real time by email
    F-3/A 1 formf-3a.htm F-3/A

     

    As filed with the U.S. Securities and Exchange Commission on February 23, 2026

     

    Registration No. 333-292111

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    AMENDMENT NO. 3 TO

    FORM F-3

     

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

    Meiwu Technology Company Limited

    (Exact name of registrant as specified in its charter)

     

    British Virgin Islands   5961   Not Applicable

    (State or other jurisdiction of

    incorporation or organization)

      (Translation of Registrant’s
    Name into English)
      (I.R.S. Employer
    Identification No.)

     

    Unit 304-3, No. 19, Wanghai Road, Siming District

    Xiamen, Fujian, People’s Republic of China, 361000

    Telephone: +86-755-85250400

    (Address and telephone number of principal executive offices)

     

    Puglisi & Associates

    850 Library Avenue, Suite 204

    Newark, DE 19711

    302-738-6680

    (Name, address including zip code, and telephone number, including area code, of agent for service)

     

    Copies to:

    Joan Wu, Esq.

    Hunter Taubman Fisher & Li LLC

    950 Third Avenue, 19th Floor

    New York, NY 10022

    Tel: (212) 530-2208

     

    Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this Registration Statement.

     

    If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

     

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

     

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

     

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

     

    If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

     

    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

     

    Emerging growth company ☒

     

    If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

    † The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

     

    The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    Meiwu Technology Company Limited is filing this Amendment No. 3 (“Amendment No. 3”) to the Registration Statement on Form F-3 (Registration No. 333-292111) (the “Registration Statement”) solely for the purpose of re-filing exhibit 23.1 to this Amendment No. 3 and amending and restating the exhibit index set forth in Part II of the Registration Statement.

     

    No changes have been made to the Registration Statement other than this explanatory note as well as changes to the cover page and Part II of the Registration Statement. This Amendment No. 3 does not contain copies of the prospectus included in the Registration Statement, which remains unchanged from Amendment No. 2 to the Registration Statement filed on January 26, 2026, and consists only of the cover page, this explanatory note and Part II of the Registration Statement.

     

     
     

     

    PART II

     

    INFORMATION NOT REQUIRED IN PROSPECTUS

     

    Item 8. Indemnification of Directors and Officers

     

    The BVI Act limits the extent to which a company articles of association may provide for indemnification of any persons, such indemnification is, only permitted where the director acted honestly and in good faith and in what he believed to be in the best interests of the company, and in the case of indemnification for criminal proceedings, the person has no reasonable cause to believe that the conduct was unlawful. In addition, under common law, indemnification provisions may be void if held by the British Virgin Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime.

     

    Our currently effective Memorandum and Articles of Association provide that we shall indemnify our directors, against all expenses, other than by reason of such indemnified person’s own dishonesty, willful default or fraud, in or about the conduct of our company’s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such indemnified person in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs in any court whether in the British Virgin Islands or elsewhere.

     

    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

     

    Item 9. Exhibits

     

    Exhibit
    No.
      Description
    1.1   Form of Underwriting Agreement**
    3.1   Memorandum and Articles of Association, currently in effect*
    4.1   Form of Warrant**
    4.2   Form of Warrant Agreement**
    4.3   Form of Unit Agreement**
    4.4   Form of indenture with respect to senior debt securities, to be entered into between registrant and a trustee acceptable to the registrant, if any#**
    4.5   Form of indenture with respect to subordinated debt securities, to be entered into between registrant and a trustee acceptable to the registrant, if any#**
    4.6   Form of debt securities, if any**
    5.1   Opinion of Conyers Dill & Pearman*
    23.1   Consent of Enrome LLP***
    23.2   Consent of Conyers Dill & Pearman (included in Exhibit 5.1)*
    24.1   Power of Attorney*
    107   Filing Fee Table*

     

    * Previously Filed
    ** To be filed by amendment or as an exhibit to a filing with the SEC under Section 13 or 15(d) of the Securities Exchange Act of 1934 and incorporated by reference in connection with the offering of securities to the extent required for any such offering.
    *** Filed herein
    # To be filed in accordance with the requirements of Section 305(b)(2) of the Trust Indenture Act of 1939 and Rule 5b-3 thereunder.

     

    II-1

     

     

    Item 10 Undertakings

     

    (a) The undersigned registrant hereby undertakes:

     

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

     

    (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
       
    (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement.
       
    (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

     

    provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b).

     

    (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
       
    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    II-2

     

     

    (4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

     

    (i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
       
    (ii) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

     

    (5) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

     

    (i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
       
    (ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;
       
    (iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
       
    (iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

     

    (b) That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
       
    (c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

     

    II-3

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Xiamen, China, on February 23, 2026, Eastern Standard Time.

     

    Meiwu Technology Company Limited  
         
    By: /s/ Zhichao Yang  
    Name: Zhichao Yang  
    Title: Chief Executive Officer  

     

    Pursuant to the requirements of the U.S. Securities Act of 1933, as amended, this Form F-3 registration statement has been signed by the following persons in the capacities and on the date indicated.

     

    Signature   Position   Date
             
    /s/ Zhichao Yang   Chief Executive Officer and Director   February 23, 2026
    Zhichao Yang   (Principal Executive Officer)    
             
    /s/ Handy Wijaya   Co-Chief Executive Officer   February 23, 2026
    Handy Wijaya        
             
    /s/ Zihao Liu   Chief Financial Officer   February 23, 2026
    Zhihao Liu   (Principal Financial and Accounting Officer)    
             
    /s/ Changbin Xia   Chairman   February 23, 2026
    Changbin Xia        
             
    /s/ Aiwei Luo   Independent Director   February 23, 2026
    Aiwei Luo        
             
    /s/ Hanwu Yang   Independent Director   February 23, 2026
    Hanwu Yang        
             
    /s/ Yan Siook Yi   Independent Director   February 23, 2026
    Yan Siook Yi        

     

    II-4

     

     

    SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

     

    Pursuant to the Securities Act of 1933 as amended, the undersigned, the duly authorized representative in the United States of America, has signed this registration statement thereto in Newark, DE, on February 23, 2026.

     

    Authorized U.S. Representative  
    Puglisi & Associates  
       
    By: /s/ Donald J. Puglisi  
    Name: Donald J. Puglisi  
    Title: Managing Director Puglisi & Associates  

     

    II-5

     

    Get the next $WNW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WNW

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $WNW
    SEC Filings

    View All

    Amendment: SEC Form F-3/A filed by Meiwu Technology Company Limited

    F-3/A - Meiwu Technology Co Ltd (0001787803) (Filer)

    2/23/26 11:39:14 AM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form 6-K/A filed by Meiwu Technology Company Limited

    6-K/A - Meiwu Technology Co Ltd (0001787803) (Filer)

    2/3/26 4:15:15 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 6-K filed by Meiwu Technology Company Limited

    6-K - Meiwu Technology Co Ltd (0001787803) (Filer)

    2/2/26 4:15:11 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    $WNW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Meiwu Technology Co., Ltd. Announces MOU with Real BioTech (Qingdao) Ltd.

    Xiamen, China, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Ltd. (hereinafter referred to as " Meiwu" or the "Company") (NASDAQ:WNW), a leading integrated platform in the beauty industry, announced that the Company signed a non-binding Strategic Cooperation Memorandum of Understanding ("MOU") on November 25, 2025, with Real BioTech (Qingdao) Ltd. ("Real Biotech"), a marine biotechnology enterprise based in Qingdao, China. The MOU aims to establish a strategic partnership between the two parties, jointly dedicated to expanding the Company's market shares in the beauty market in China and globally.​ Pursuant to the terms of the MOU, both parties will integrate their core strength

    12/3/25 5:00:00 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    Meiwu Technology Company Limited and Shenzhen Zhinuo Weichuang Technology Co., Ltd Form Strategic Partnership

    SHENZHEN, China, July 02, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ:WNW) announced today that today that it entered into an agreement with Shenzhen Zhinuo Weichuang Technology Co., Ltd. ("Zhinuo Weichuang") to enhance the Company's brand influence and market competitiveness. Zhinuo Weichuang, based in Guangdong China, primarily engages in the research, development, and sale of technology products in the fields of smart technology, AI-driven finance, and the internet, as well as the provision of intelligent services and investment-related activities. The Company engaged Zhinuo Weichuang for its comprehensive marketing services for a term fr

    7/1/25 4:15:00 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    Meiwu Technology Company Limited and Shenzhen Zhinuoweichuang Technology Co., Ltd Form Strategic Partnership

    Shenzhen, China, June 17, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ:WNW) announced today that today that it entered into an agreement with Shenzhen Zhinuo Weichuang Technology Co., Ltd.("Zhinuo Weichuang") to enhance the Company's brand influence and market competitiveness. Zhinuo Weichuang, based in Guangdong China, primarily engages in the research, development, and sale of technology products in the fields of smart technology, AI-driven finance, and the internet, as well as the provision of intelligent services and investment-related activities. The Company engaged Zhinuo Weichuang for its comprehensive marketing services for a term fro

    6/17/25 8:30:00 AM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    $WNW
    Financials

    Live finance-specific insights

    View All

    Meiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency

    Shenzhen, China, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ:WNW) announced today that on September 10, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company's ordinary shares on Nasdaq. Under the Nasdaq Li

    9/11/24 4:15:00 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    Meiwu Technology Co., Limited Received Nasdaq Notification Letter Related to Late Filing of Annual Report on Form 20-F

    Shenzhen, China, June 05, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Limited (NASDAQ:WNW) ("Meiwu" or the "Company"), an online and mobile commerce company providing organic and green food products to customers on its online platform and in its stores, enterprise short message service ("SMS") and information technology to serve designated medical insurance institutions in China, announced today that it has received a letter from the Nasdaq Stock Market, dated May 31, 2024 (the "Deficiency Letter"), notifying the Company that it is not in compliance with the requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because it did not timely file its annual report on

    6/5/24 9:00:00 AM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    Meiwu Technology Co., Limited Regains Compliance with Nasdaq Listing Requirements

    Shenzhen, China, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Limited (NASDAQ:WNW) ("Meiwu" or the "Company"), an online and mobile commerce company providing organic and green food products to customers on its online platform and in its stores, enterprise short message service ("SMS") and information technology to serve designated medical insurance institutions in China. The Company today announced on January 9, 2024, it received notice from the NASDAQ Office of General Counsel that the bid price deficiency of Meiwu's ordinary shares has been cured, and Meiwu has regained compliance with NASDAQ Marketplace Rule 5550(a)(2). As a result, a previously scheduled hearin

    1/18/24 8:30:00 AM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    $WNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Meiwu Technology Company Limited

    SC 13G - Meiwu Technology Co Ltd (0001787803) (Subject)

    10/31/23 4:24:23 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G filed by Meiwu Technology Company Limited

    SC 13G - Meiwu Technology Co Ltd (0001787803) (Subject)

    10/31/23 4:22:35 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G filed by Meiwu Technology Company Limited

    SC 13G - Meiwu Technology Co Ltd (0001787803) (Subject)

    10/31/23 4:19:58 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary